Real-world assessment of response to anti-programmed cell death 1 therapy in advanced cutaneous squamous cell carcinoma

J Am Acad Dermatol. 2021 Oct;85(4):1038-1040. doi: 10.1016/j.jaad.2021.01.048. Epub 2021 Jan 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Carcinoma, Squamous Cell* / drug therapy
  • Humans
  • Programmed Cell Death 1 Receptor
  • Skin Neoplasms* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Programmed Cell Death 1 Receptor